India’s Largest Microcrystalline Cellulose Manufacturing Plant Inaugurated By Gadkari

Nagpur : Nitika Pharmaceuticals Specialty Private Limited, excipient manufacturing company, marked a historic milestone with the grand inauguration of India’s largest Microcrystalline Cellulose (*Tabcell) Manufacturing Plant, an event that reverberated with the presence of esteemed dignitaries, eminent guests, and global industry leaders.

The grand ceremony, which took place on Saturday, 16th September, 2023, at Butibori, Nagpur was a resounding success and a momentous occasion for the pharmaceutical and excipient manufacturing sectors.

The inauguration of this state-of-the-art manufacturing plant was graced by the presence of two eminent leaders, Hon’ble Shri Nitin Gadkari – Minister Road Transport and Highways India, and Shri Devendra Fadnavis – Deputy Chief Minister – Maharashtra. Their esteemed presence added prestige to the event and underscored its significance in the industry. Additionally, the ceremony saw the participation of special guests, including Shri. Ajay Sancheti, Shri. Sameer Meghe, and Shri. Sandeep Joshi, who all contributed to the grandeur of the occasion.

During his speech, Hon’ble Shri Nitin Gadkari congratulated Nitika Pharmaceuticals company for receiving the Production Linked Incentive (PLI) scheme from the Government of India. This achievement underlines the company’s commitment to excellence and innovation in the pharmaceutical sector. Shri Nitin Gadkari also commended on how Nitika Pharmaceutical is actively contributing in Government of India’s “Atma Nirbhar Bharat” OR “Make in India” mission by manufacturing the excipients of international standard in India and exporting the same globally in more than 92 countries worldwide.

Along with the magnificent inauguration of India’s largest Microcrystalline cellulose manufacturing plant the distinguished Chief Guest also laid the foundation stone and performed ‘bhumi pujan’ for two more upcoming plants which will generate 750 plus employment in next 2 year, showcasing Nitika Pharmaceuticals dedication to further growth and expansion in the industry.

.The event drew nearly 1000 prominent guests from across the globe, reflecting its international significance and impact. The enthusiastic participation of industry leaders, stakeholders, and international representatives highlighted the global importance of the occasion.

The newly inaugurated Microcrystalline Cellulose Manufacturing Plant at Nagpur is equipped with cutting-edge technology and infrastructure, making it the largest and most advanced facility of its kind in India with an installed capacity of 20 symbolizes Nitika Pharmaceuticals’ commitment to quality, innovation, and sustainable manufacturing practices, setting new industry standards.

The success of this grand inauguration ceremony marks a significant milestone not only for Nitika Pharmaceuticals Specialty Private Limited but also for the entire pharmaceutical and excipient manufacturing sector in India. This inauguration  reinforces India’s position as “pharmacy of the World”.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?